BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 7882573)

  • 1. Screening for anti-neutrophil cytoplasmic antibodies (ANCA): is indirect immunofluorescence the method of choice?
    Baslund B; Segelmark M; Wiik A; Szpirt W; Petersen J; Wieslander J
    Clin Exp Immunol; 1995 Mar; 99(3):486-92. PubMed ID: 7882573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical evaluation of a capture ELISA for detection of proteinase-3 antineutrophil cytoplasmic antibody.
    Westman KW; Selga D; Bygren P; Segelmark M; Baslund B; Wiik A; Wieslander J
    Kidney Int; 1998 May; 53(5):1230-6. PubMed ID: 9573537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human mast cells expressing recombinant proteinase 3 (PR3) as substrate for clinical testing for anti-neutrophil cytoplasmic antibodies (ANCA).
    Specks U; Wiegert EM; Homburger HA
    Clin Exp Immunol; 1997 Aug; 109(2):286-95. PubMed ID: 9276524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A critical evaluation of commercial immunoassays for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase in Wegener's granulomatosis and microscopic polyangiitis.
    Csernok E; Ahlquist D; Ullrich S; Gross WL
    Rheumatology (Oxford); 2002 Nov; 41(11):1313-7. PubMed ID: 12422006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Image analysis: a novel approach for the quantification of antineutrophil cytoplasmic antibody levels in patients with Wegener's granulomatosis.
    Boomsma MM; Damoiseaux JG; Stegeman CA; Kallenberg CG; Patnaik M; Peter JB; Tervaert JW
    J Immunol Methods; 2003 Mar; 274(1-2):27-35. PubMed ID: 12609530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurements of proteinase 3 and its complexes with alpha 1-proteinase inhibitor and anti-neutrophil cytoplasm antibodies (ANCA) in plasma.
    Baslund B; Petersen J; Permin H; Wiik A; Wieslander J
    J Immunol Methods; 1994 Oct; 175(2):215-25. PubMed ID: 7930650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capture-ELISA based on recombinant PR3 is sensitive for PR3-ANCA testing and allows detection of PR3 and PR3-ANCA/PR3 immunecomplexes.
    Sun J; Fass DN; Hudson JA; Viss MA; Wieslander J; Homburger HA; Specks U
    J Immunol Methods; 1998 Feb; 211(1-2):111-23. PubMed ID: 9617836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical spectrum associated with ANCA of defined antigen specificities in 98 selected patients.
    Geffriaud-Ricouard C; Noël LH; Chauveau D; Houhou S; Grünfeld JP; Lesavre P
    Clin Nephrol; 1993 Mar; 39(3):125-36. PubMed ID: 7681736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection rate and antigenic specificities of antineutrophil cytoplasmic antibodies in chinese patients with clinically suspected vasculitis.
    Xin G; Zhao MH; Wang HY
    Clin Diagn Lab Immunol; 2004 May; 11(3):559-62. PubMed ID: 15138182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant proteinase 3 produced in different expression systems: recognition by anti-PR3 antibodies.
    van der Geld YM; Oost-Kort W; Limburg PC; Specks U; Kallenberg CG
    J Immunol Methods; 2000 Oct; 244(1-2):117-31. PubMed ID: 11033024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies to proteinase 3 and myeloperoxidase in systemic sclerosis.
    Ruffatti A; Sinico RA; Radice A; Ossi E; Cozzi F; Tonello M; Grypiotis P; Todesco S
    J Rheumatol; 2002 May; 29(5):918-23. PubMed ID: 12022350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antineutrophil cytoplasmic antibody measurement: advantages and disadvantages of a capture PR3 ELISA and a direct PR3 ELISA.
    O'Donnell JL; Hayman MW; Spellerberg MB; McLellan AD; Brooksbank K; Chapman PT; Stamp LK
    Pathology; 2007 Apr; 39(2):258-63. PubMed ID: 17454758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of immunofluorescence to the identification and characterization of anti-neutrophil cytoplasmic autoantibodies. The role of different fixatives.
    Radice A; Vecchi M; Bianchi MB; Sinico RA
    Clin Exp Rheumatol; 2000; 18(6):707-12. PubMed ID: 11138332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of capture ELISA for detection of antineutrophil cytoplasmic antibodies directed against proteinase 3 in Wegener's granulomatosis: first results from a multicentre study.
    Csernok E; Holle J; Hellmich B; Willem J; Tervaert C; Kallenberg CG; Limburg PC; Niles J; Pan G; Specks U; Westman K; Wieslander J; De Groot K; Gross WL
    Rheumatology (Oxford); 2004 Feb; 43(2):174-80. PubMed ID: 14585921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relevance of classic anti-neutrophil cytoplasmic autoantibody (C-ANCA)-mediated inhibition of proteinase 3-alpha 1-antitrypsin complexation to disease activity in Wegener's granulomatosis.
    Dolman KM; Stegeman CA; van de Wiel BA; Hack CE; von dem Borne AE; Kallenberg CG; Goldschmeding R
    Clin Exp Immunol; 1993 Sep; 93(3):405-10. PubMed ID: 8370167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization.
    Hagen EC; Daha MR; Hermans J; Andrassy K; Csernok E; Gaskin G; Lesavre P; Lüdemann J; Rasmussen N; Sinico RA; Wiik A; van der Woude FJ
    Kidney Int; 1998 Mar; 53(3):743-53. PubMed ID: 9507222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indirect immunofluorescence (IIF) of normal washed peripheral blood cells to demonstrate antineutrophil cytoplasmic antibodies (ANCA).
    Paspaliaris B; Pamio M; Savige J
    J Clin Pathol; 2000 Oct; 53(10):774-7. PubMed ID: 11064672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of classical and atypical antineutrophil cytoplasmic antibody (ANCA) immunofluorescence patterns.
    Wong RC; Silvestrini RA; Savige JA; Fulcher DA; Benson EM
    J Clin Pathol; 1999 Feb; 52(2):124-8. PubMed ID: 10396240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low seroprevalence and poor specificity of antineutrophil cytoplasmic antibodies in tuberculosis.
    Teixeira L; Mahr A; Jaureguy F; Noël LH; Nunes H; Lefort A; Barry S; Deny P; Guillevin L
    Rheumatology (Oxford); 2005 Feb; 44(2):247-50. PubMed ID: 15546964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of eight commercial kits for quantitation of antineutrophil cytoplasmic antibodies (ANCA).
    Wang G; Csernok E; de Groot K; Gross WL
    J Immunol Methods; 1997 Oct; 208(2):203-11. PubMed ID: 9433475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.